PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Racial stereotypes can make us see weapons where they don’t exist

2025-09-09
(Press-News.org) Unarmed Black civilians are three times more likely to be shot and killed by police officers than unarmed white civilians in the U.S. In tragic cases in recent years, unarmed Black men holding innocuous objects like a wallet, cell phone, or vape pen were killed by police officers because those objects were misidentified as weapons. These split-second fatal mistakes, often under ambiguous and stressful conditions, have sparked urgent debates about their causes and how to fix them.

A new brain-imaging study from researchers at Columbia University suggests that part of the problem is that racial stereotypes can infiltrate the brain’s visual system, prompting us to see objects in ways that conform to these stereotypes. These stereotypes transiently distort how the brain quite literally sees a harmless object. Using functional magnetic resonance imaging (fMRI) and cutting-edge neural decoding techniques, the researchers found that when participants saw everyday graspable objects like a wrench or drill after briefly viewing a Black man’s face, object-processing regions in the brain shifted their neural representation to more closely resemble that of a weapon.

Participants were also asked to sort images, identifying them as either weapons or tools. They consistently showed milliseconds of delay in categorizing tools as tools rather than as weapons when the image was immediately followed by a Black man’s face, indicating an initial unconscious tendency to perceive them as weapons. The researchers then specifically linked this weapon identification bias to the shifts in the brain’s visual system they observed: The more that test subjects’ brains shifted toward a weapon reaction when they saw a tool followed by a Black man’s face, the longer the delay they experienced before successfully resolving the tool as a tool, not a weapon. In some cases, particularly when responding very quickly, subjects made full-blown errors such that tool images followed by a Black man’s face were misidentified as weapons altogether.

The study was led by Jon Freeman, an associate professor of psychology at Columbia, and published in the journal Nature Communications. The other authors, previously in Freeman’s lab group at Columbia, include DongWon Oh, an assistant professor of psychology at National University of Singapore, and Henna Vartiainen, a doctoral candidate at Princeton University.

“Our findings demonstrate that the stereotypes we hold can alter the brain’s visual representation of an object, distorting what we see to fit our biased expectations,” Freeman said.

The findings were robust, replicated across two large and racially diverse samples, and occurred in participants of all racial backgrounds, consistent with the fact that these stereotypes are learned by all members of society. The study included fMRI imaging of 31 subjects from the New York City area, and tested racially biased weapon identification on 422 additional online subjects based around the U.S. The researchers compared study subjects’ reactions to images of Black and white men.

These kinds of racial bias effects on weapon identification have previously been observed in samples of both civilians and police officers, but this is the first brain-imaging study to look into the mechanisms involved. Previous research has linked weapon identification biases with stereotypes that associate Black individuals with crime and danger. Researchers have largely believed that these weapon identification biases do not stem from any visual distortion, instead assuming that people see the object accurately but are then unable to control their racially biased impulses. This new study suggests that an overlooked part of the problem is that stereotypes are creating a temporary visual distortion as well.

By showing that stereotypes can alter perception itself—not just conscious decisions—the findings add a crucial layer to understanding why racially biased mistakes happen in high-stakes contexts like policing.

The work opens the door to new interventions that could target visual perception, which the researchers plan to explore in future research. For instance, repeatedly pairing images of Black men with everyday tools rather than weapons could retrain the visual system, weakening the automatic bias to see a weapon where none exists. Counterintuitively, the opposite may also be true: much like how the eyes adjust after staring into bright light, prolonged exposure to Black-weapon pairings might fatigue the bias itself, allowing neutral objects to be perceived more accurately. The team is planning to explore which possible remedies yield the greatest success.

“We’re eager to build on this research by exploring new interventions that might recalibrate biased visual perceptions,” Freeman said, noting that traditional bias-reduction strategies have fallen short. “Our findings suggest a new direction: targeting not just the stereotypes people hold, but also the visual processes that shape how we see others. If we can change split-second perceptual distortions, we may be able to mitigate these kinds of consequential misjudgments in high-stakes situations under stress and uncertainty.”

END


ELSE PRESS RELEASES FROM THIS DATE:

“Bottlebrush” particles deliver big chemotherapy payloads directly to cancer cells

2025-09-09
CAMBRIDGE, MA -- Using tiny particles shaped like bottlebrushes, MIT chemists have found a way to deliver a large range of chemotherapy drugs directly to tumor cells. To guide them to the right location, each particle contains an antibody that targets a specific tumor protein. This antibody is tethered to bottlebrush-shaped polymer chains carrying dozens or hundreds of drug molecules — a much larger payload than can be delivered by any existing antibody-drug conjugates. In mouse models of breast and ovarian cancer, the researchers found that treatment with ...

New AI tool pinpoints genes, drug combos to restore health in diseased cells

2025-09-09
In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells. Unlike traditional approaches that typically test one protein target or drug at a time in hopes of identifying an effective treatment, the new model, called PDGrapher and available for free, focuses on multiple drivers of disease and identifies the genes most likely to revert diseased cells back to healthy function. The ...

Predicting where deadly brain cancer may spread next

2025-09-09
Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but that only buys time. The cancer has an insidious ability to hide enough tumor cells in tissue around the tumor to allow it to return as deadly as ever. Patients diagnosed with glioblastoma survive for an average of 15 months. What’s needed is a better way of identifying those hidden cancer cells and predicting where the tumor might grow next. Jennifer Munson believes she and her research team at the Fralin Biomedical Research Institute at VTC have developed a tool to do just that. Their method, described ...

First ever measure of boron in individual cancer cells could revolutionise drug understanding

2025-09-09
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumours in some cancers.   In a new article in the Journal of Analytical Atomic Spectrometry, a team from the University of Birmingham funded by the Rosetrees Trust have for the first time used a technology to conduct real-time measurement of boron in live tumour cells.  The technique, called single-cell ICP-MS, enabled the team to see how and when treatments for head and neck cancers enter and exit tumour cells.   Boron Neutron Capture Therapy (BNCT) is a new form of therapeutic for head and neck cancer that involves ...

Graz researchers discover what stiffens the aorta

2025-09-09
Cardiovascular diseases remain the most common cause of death worldwide. In Europe, they account for over 40 percent of all deaths. However, known risk factors such as high cholesterol levels or high blood pressure cannot fully explain the high mortality rate or the number of cardiovascular diseases. Scientists in Graz have now investigated a new factor that is closely linked to cardiovascular mortality. Elevated levels of the amino acid homocysteine in the blood led to a stiffer and less elastic aorta in an animal model. These findings contribute to the current understanding ...

Breakthrough in atomic-level etching of hafnium oxide, a promising material for advanced semiconductors

2025-09-09
Hafnium oxide (HfO2) has attracted attention as a promising material for ultrathin semiconductors and other microelectronic devices. The strong ionic bond between hafnium and oxygen atoms in HfO2 gives it a high dielectric constant, superior thermal stability, and a wide band gap. Notably, these properties can be maintained even at the atomic scale. Meanwhile, these properties also pose challenges in achieving highly precise and smooth etching of HfO2 films. Now, a group of researchers from Japan and Taiwan has successfully etched HfO2 films with atomic-level precision, smoothness, ...

How evolution explains autism rates in humans

2025-09-09
A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that the relatively high rate of Autism-spectrum disorders in humans is likely due to how humans evolved in the past. About one in 31 (3.2%) children in the United States has been identified with Autism Spectrum Disorder. Globally, the World Health Organization estimates that around one in 100 children have autism. From an evolutionary perspective, many scientist believe that autism and schizophrenia may be unique to humans. ...

Swedish psychologist transforms mental health access through digital therapy revolution

2025-09-09
LINKÖPING, SWEDEN, 9 September 2025 -- In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Gerhard Andersson traces his extraordinary journey from skateboarding punk musician to becoming the architect of a global revolution in psychological treatment delivery. The comprehensive interview unveils how two graduate students knocking on his office door in 1998 sparked a transformation that would fundamentally alter how millions access mental healthcare worldwide. From Uppsala Laboratory to Global Impact Dr. Andersson's path to scientific prominence began unexpectedly ...

Centenarian neuroscientist inspires blueprint for vibrant longevity through mentorship and connection

2025-09-09
TUCSON, Arizona, USA, 9 September 2025 -- A viewpoint article published today in Brain Medicine by Dr. Esther Sternberg provides a compelling portrait of how one pioneering neuroscientist continues to thrive beyond his centennial year. The tribute to Dr. Seymour Reichlin, published as part of a special Festschrift commemorating his 100th birthday, examines the multifaceted elements that have sustained his remarkable intellectual vigor and social vitality at 101 years old. Dr. Sternberg, who has directed research at the Andrew Weil Center for Integrative ...

King’s College London researcher advances psychiatric genomics through pioneering polygenic scoring innovations

2025-09-09
LONDON, England, UNITED KINGDOM, 9 September 2025 -- In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr Oliver Pain reveals how personal experiences and scientific curiosity converged to reshape global approaches to psychiatric genomics. The Sir Henry Wellcome Postdoctoral Research Fellow transforms how scientists worldwide understand and apply genetic risk prediction for mental health disorders, developing tools that democratize access to cutting-edge genomic methodologies across international research communities. The interview illuminates Dr Pain's evolution ...

LAST 30 PRESS RELEASES:

Gut microbiome influences proteins that drive aging and disease

NIH funds first-of-its-kind center to study resilience and aging

Mesonephric carcinoma and mesonephric-like adenocarcinoma of the female genital tract

Rural patients in the United States still face barriers to telehealth access

Emphysema at CT lung screening increases death risk in asymptomatic adults

Brain iron on MRI predicts cognitive impairment, decline

The ISSCR partners with Nuffield Council on Bioethics to compile global horizon scan on stem cell research

Machine learning unveils COPD patient clusters and quality of life associations in China

No sign of toxic effects of inhaled anesthesia in young children

CUNY SPH expands curriculum with concentration in sexual and reproductive justice and health

High consumption of ultra-processed foods linked to systemic inflammation

City of Hope launches transformative national clinical trials model to accelerate cancer research

Inside an academic scandal: a story of fraud and betrayal

Innovative ultrasonic regeneration restores nano-phase change emulsions for low-temperature applications

Targeted snow monitoring at hotspots outperforms basin-wide surveys in predicting water supply

Decades-old barrels of industrial waste still impacting ocean floor off Los Angeles

Finalists announced for the 2025 Blavatnik National Awards for Young Scientists

Alkali waste dumped in the Pacific Ocean created alkalophilic ecosystems

Bacterial ink to restore coral reefs

AI-based satellite count of migrating wildebeest

Bee-sting inspired microneedles from Chung-Ang University could revolutionize drug delivery

Pusan National University researchers reveal how uneven ocean warming is altering propagation of the Madden-Julian oscillation

Mapping causality in neuronal activity: towards a better understanding of brain networks

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Scientists find curvy answer to harnessing “swarm intelligence”

PALOMA-2 study: Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

First 3D real-time imaging of hydrogen’s effect on stainless steel defects opens the way to a safer hydrogen economy

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with inadequate response to immune checkpoint inhibitors

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

[Press-News.org] Racial stereotypes can make us see weapons where they don’t exist